Skip to main content
. 2023 Jan;384(1):72–78. doi: 10.1124/jpet.122.001250

Fig. 4.

Fig. 4.

Effect of treatment on circulating miR-1 in Fabry disease (FD). Evaluation of mitomiRs in untreated and treated FD patients. Untreated FD patients show a reduction in circulating miR-1; treatment restores miR-1 levels in FD patients to the levels observed in control subjects. Data are mean ± S.E. *P < 0.05 versus controls; **P <0.05 versus untreated FD patients.